Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07431944 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Silencing Neuroma Pain-Botulinum Toxin Versus Local Anesthetic Injection

Study acronym: SILENCE-NEUROM
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Neuroma-related pain is a frequent and disabling condition after limb trauma and amputation. Available treatments often provide short-lasting or insufficient analgesia. The SILENCE-NEUROMA Trial is a multicenter, randomized, double-blind, active-controlled study designed to compare the efficacy and safety of botulinum toxin type A versus local anesthetic injection for the treatment of neuroma-related pain. The primary outcome is pain reduction at 8 weeks after treatment.
Trial Details
NCT Number NCT07431944
Lead Sponsor Charitable Organisation Charitable Fund Superhumans (Co Cf Superhumans)
Conditions
(from sponsor)		 Pain Management, Pain, Phantom Limb Pain, Phantom Limb Pain After Amputation
Related terms Agnosia, Chronic Pain, Pain, Phantom Limb
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov